Clinical Trials on Atypical Endometrial Hyperplasia and Endometrial Cancer

Total 1453 results

West China Second University Hospital

Recruiting

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Atypical Endometrial Hyperplasia | Endometrial Cancer

China
IRCCS Burlo Garofolo

Completed

Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women

Atypical Endometrial Hyperplasia | Atypical Endometrial Polyps

Italy
Zagazig University

Completed

LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

Egypt
Fudan University
Zhejiang Cancer Hospital; Shanghai 6th People's Hospital; Shanghai Changning...

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia

China
Krankenhaus Barmherzige Schwestern Linz

Completed

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Endometrial Cancer | Atypical Hyperplasia

Austria
Fudan University

Terminated

Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

China
National Cancer Institute (NCI)

Active, not recruiting

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical Hyperplasia

United States
Beijing Obstetrics and Gynecology Hospital

Not yet recruiting

Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

Atypical Endometrial Hyperplasia and Endometrial Cancer
Eli Lilly and Company
Gynecologic Oncology Group

Completed

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Uterine Neoplasms | Genital Neoplasms, Female | Endometrial Neoplasms | Endometrial Cancer | Endometrium Cancer | Cancer of Endometrium | Cancer of the Endometrium | Neoplasms, Endometrial

United States
University Health Network, Toronto

Recruiting

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (B-FiERCE)

Bariatric Surgery Candidate | Endometrial Cancer | Atypical Hyperplasia

Canada
University Health Network, Toronto

Not yet recruiting

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (WE-FiERCE)

Endometrial Cancer | Atypical Hyperplasia
Peking University People's Hospital

Recruiting

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia | Endometrial Carcinoma Stage I

China
NYU Langone Health

Completed

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

Atypical Endometrial Hyperplasia | Endometrial Carcinoma

United States
Xiaojun Chen
Huashan Hospital

Withdrawn

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia | Fertility Issues | Obese
CHU de Reims

Unknown

Role of Senescence in the Development of Endometrial Cancer

Endometrial Hyperplasia and Endometrial Cancers

France
Kocaeli University

Completed

Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia

Endometrial Hyperplasia Without Atypia

Turkey
Pirogov Russian National Research Medical University

Completed

Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes

Endometrial Cancer | Endometrial Hyperplasia Without Atypia | Postmenopause | Peripheral Blood Mononuclear Cells | Endometrial Hyperplasia With Atypia | Estrogen Receptor | Progesterone Receptor
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

Atypical Endometrial Hyperplasia | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Stage IA Endometrial Carcinoma | Stage IB Endometrial Carcinoma | Stage II Endometrial Carcinoma | Stage IIIA Endometrial Carcinoma | Stage IIIB Endometrial Carcinoma | Stage IIIC Endometrial Carcinoma | Stage... and other conditions
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia

Stage II Uterine Corpus Cancer | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus Cancer | Complex Endometrial Hyperplasia With Atypia

United States
Xiaojun Chen

Completed

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Endometrial Hyperplasia Without Atypia

China
UNC Lineberger Comprehensive Cancer Center

Completed

Metformin for the Treatment of Endometrial Hyperplasia

Endometrial Hyperplasia | Endometrial Hyperplasia Without Atypia

United States
Regina Elena Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University of... and other collaborators

Active, not recruiting

Endometrial Changes in Breast Cancer Women.

Breast Cancer | Endometrial Cancer | Endometrial Hyperplasia With Atypia | TAM

Italy
Peking University People's Hospital
Peking University; Beihang University

Recruiting

Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

Atypical Endometrial Hyperplasia | Endometrial Carcinoma Stage I

China
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

Atypical Endometrial Hyperplasia | Endometrial Carcinoma

United States
Sohag University

Not yet recruiting

the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

Endometrial Cancer and Endometrial Hyperplasia

Egypt
Fudan University

Completed

Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

China
Peking University People's Hospital

Recruiting

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I

China
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Atypical Endometrial Hyperplasia | Endometrial Neoplasms | Progesterone Resistance

China
Università degli Studi dell'Insubria
Universita di Verona

Not yet recruiting

PET/CT in the Management of Patients With Early Stage Endometrial Cancer (ENCA-1)

Endometrium Cancer
Imperial College London

Recruiting

Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?

Endometrial Hyperplasia | Endometrial Neoplasms | Endometrial Cancer | Endometrial Polyp

United Kingdom
Imperial College London

Completed

Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?

Endometrial Hyperplasia | Endometrial Neoplasms | Endometrial Cancer | Endometrial Diseases

United Kingdom
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Obesity | Atypical Endometrial Hyperplasia | Endometrial Neoplasms | Progesterone Resistance

China
Women and Infants Hospital of Rhode Island

Unknown

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Grade 1 Endometrial Endometrioid Adenocarcinoma | Grade 2 Endometrial Endometrioid Adenocarcinoma | Complex Atypical Endometrial Hyperplasia

United States
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

Obesity | Atypical Endometrial Hyperplasia | Progesterone Resistance

China
Fudan University

Recruiting

Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

Obesity | Atypical Endometrial Hyperplasia | Fertility Issues

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (LEVER)

Atypical Endometrial Hyperplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

United States
National Cancer Institute (NCI)

Suspended

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Endometrial Cancer | Endometrial Carcinoma | Cancer of Endometrium | Carcinoma of Endometrium

United States
Università degli Studi di Ferrara

Recruiting

Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma

Cancer of Endometrium

Italy
Vancouver Coastal Health Research Institute
University of British Columbia

Recruiting

Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia (FETCH)

Gynecologic Cancer | Endometrial Hyperplasia | Endometrial Cancer

Canada
Rajavithi Hospital

Completed

Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells

Metformin | CA Endometrium

Thailand
Nottingham University Hospitals NHS Trust

Recruiting

Vibrational Spectroscopy for Endometrial Cancer Diagnosis (SPEED)

Endometrial Hyperplasia | Endometrial Cancer

United Kingdom
Imperial College London

Unknown

Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?

Endometrial Hyperplasia | Endometrial Neoplasms | Endometrial Cancer

United Kingdom
University of the Philippines
Organon

Not yet recruiting

The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study

Endometrial Hyperplasia Without Atypia
Rabin Medical Center
Ferring Pharmaceuticals

Unknown

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Endometrial Hyperplasia | Endometrial Cancer

Israel
UNC Lineberger Comprehensive Cancer Center
Golfers Against Cancer Grant

Active, not recruiting

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Endometrial Cancer | Complex Atypical Hyperplasia

United States
Philipps University Marburg Medical Center
German Cancer Aid

Recruiting

Endometrial Cancer Lymphadenectomy Trial (ECLAT)

Cancer of Endometrium Stage I | Cancer of Endometrium Stage II

Japan, Germany, Korea, Republic of
Academisch Medisch Centrum - Universiteit van Amsterdam...
Merck Sharp & Dohme LLC; PTC Therapeutics

Recruiting

Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study (ATAPEMBRO)

Colorectal Cancer | Endometrium Cancer

Netherlands
Xiaojun Chen
Zhejiang Cancer Hospital; Fudan University; Shanghai 6th People's Hospital; Shanghai...

Completed

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

Endometrial Adenocarcinoma | Endometrial Atypical Hyperplasia

China
Queensland Centre for Gynaecological Cancer
National Health and Medical Research Council, Australia; Johnson & Johnson... and other collaborators

Completed

Laparoscopic Approach to Cancer of the Endometrium

Endometrial Cancer

United Kingdom, Australia, Hong Kong, New Zealand
Washington University School of Medicine
ScaleDown

Completed

Scale Down for Endometrial Cancer

Endometrial Cancer | Cancer of the Endometrium

United States

Clinical Trials on Atypical Endometrial Hyperplasia and Endometrial Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations